CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 10.26: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.81BCNY416.72M · vs all stocks (USD)
Revenue (TTM)
345.51MCNY51.31M · vs all stocks (USD)
Profit Margin
-3.12%vs Medical Instruments & Supplies peers
Beta
0.5260xvs all stocks
52-Week Change
-33.15%vs all stocks
Market Capitalization
2.81BCNY416.72M · vs all stocks (USD)
Enterprise Value
3.00BCNY445.87M · vs all stocks (USD)
Price to Sales (TTM)
8.65xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
4.51xvs Medical Instruments & Supplies peers
Enterprise to Revenue
8.69xvs Medical Instruments & Supplies peers
Gross Margin
66.18%vs Medical Instruments & Supplies peers
Profit Margin
-3.12%vs Medical Instruments & Supplies peers
Operating Margin
-7.95%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-1.14%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-1.98%vs Medical Instruments & Supplies peers
Revenue (TTM)
345.51MCNY51.31M · vs all stocks (USD)
Revenue per Share (TTM)
2.74CNYUpdated Aug 20, 2026Quarterly Revenue Growth
5.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
236.69MCNY35.15M · vs all stocks (USD)
EBITDA (TTM)
-1.59MCNY-236.57K · vs all stocks (USD)
Net Income (TTM)
-10.76MCNY-1.60M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-47.07%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
15.84MCNY2.35M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
18.93MCNY2.81M · vs all stocks (USD)
Payout Ratio
75.85%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
12.23MCNYFY2025 · Dec 31, 2025Revenue
342.02MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
107.94MCNYFY2025 · Dec 31, 2025Gross Profit
234.07MCNYFY2025 · Dec 31, 2025Operating Income
-25.89MCNY-3.84M · vs all stocks (USD)
Pre-tax Income
-26.08MCNYFY2025 · Dec 31, 2025Income Tax Expense
747.37KCNYFY2025 · Dec 31, 2025Net Income
-26.83MCNYFY2025 · Dec 31, 2025EBIT
-22.83MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-1.62MCNYFY2025 · Dec 31, 2025Research & Development
40.56MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
138.66MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.09MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
497.51KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
3.26MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1906CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1906CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
126.03MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
126.03MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-26.83MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
2.81MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-8.69MCNYFY2025 · Dec 31, 2025Free Cash Flow
-16.93MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
159.62MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-26.83MCNYFY2025 · Dec 31, 2025Other Non-cash Items
7.24MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
7.02MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
3.88MCNYFY2025 · Dec 31, 2025Capital Expenditures
-8.23MCNYFY2025 · Dec 31, 2025Net Acquisitions
-13.06MCNYFY2025 · Dec 31, 2025Purchase of Investments
-42.50MCNYFY2025 · Dec 31, 2025Other Investing Activity
2.96MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-60.84MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
93.60MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-58.40MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-10.13MCNYFY2025 · Dec 31, 2025Other Financing Charges
-8.59MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
16.49MCNYFY2025 · Dec 31, 2025Shares Outstanding
126.05MSharesUpdated Aug 20, 2026Float Shares
74.19MSharesUpdated Aug 20, 2026% Held by Insiders
41.71%vs all stocks
% Held by Institutions
7.20%vs all stocks
Total Cash (MRQ)
96.52MCNY14.33M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7660CNYUpdated Aug 20, 2026Total Debt (MRQ)
98.59MCNY14.64M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1462xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.91xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
5.26CNYUpdated Aug 20, 2026Total Assets
859.71MCNY127.68M · vs all stocks (USD)
Total Current Assets
396.56MCNYFY2025 · Dec 31, 2025Total Liabilities
180.03MCNYFY2025 · Dec 31, 2025Total Non-current Assets
463.15MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
26.75MCNYFY2025 · Dec 31, 2025Total Current Liabilities
153.28MCNYFY2025 · Dec 31, 2025Cash
160.19MCNYFY2025 · Dec 31, 2025Cash Equivalents
4.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
164.60MCNYFY2025 · Dec 31, 2025Accounts Receivable
139.73MCNYFY2025 · Dec 31, 2025Inventory
57.29MCNYFY2025 · Dec 31, 2025Accounts Payable
13.54MCNYFY2025 · Dec 31, 2025Short-term Debt
93.45MCNYFY2025 · Dec 31, 2025Other Current Liabilities
4.54MCNYFY2025 · Dec 31, 2025Long-term Debt
25.14MCNYFY2025 · Dec 31, 2025Common Stock (Book)
126.05MCNYFY2025 · Dec 31, 2025Retained Earnings
156.69MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
679.67MCNY100.94M · vs all stocks (USD)
52-Week Low
16.91CNYUpdated Aug 20, 202652-Week High
44.12CNYUpdated Aug 20, 202652-Week Change
-33.15%vs all stocks
Beta
0.5260xvs all stocks
50-Day MA
21.10CNYUpdated Aug 20, 2026200-Day MA
27.55CNYUpdated Aug 20, 2026Avg 10-Day Volume
16.81MSharesUpdated Aug 20, 2026Avg 30-Day Volume
15.02MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
-0.0800CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.66Profit Margin: -0.03
Financial Health
Altman Z-Score 10.26: safe zoneNotable
Altman Z-Score: 10.26
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
TSEC Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Clearfield Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jiangsu Luokai Mechanical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Wells Advanced Materials S.A.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shenzhen Glory Medical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Jinfei Kaida Wheels Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou Kaierda Welding Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Guangdong Dcenti Auto Parts Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suli Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Izmir Demir Celik Sanayi A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Nanjing Xinjiekou Department Store Co. Ltd.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Wave Life Sciences Ltd.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
SM Entertainment Co., Ltd.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity